{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:55:42Z","timestamp":1790729742252,"version":"4.1.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00134-026-08574-4","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:12:46Z","timestamp":1787731966000},"page":"2160-2177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["State-of-the-art review: \u00df-blockade in critical illness"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9500-9080","authenticated-orcid":false,"given":"Marlies","family":"Ostermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Belley-Cote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Cecconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2888-4111","authenticated-orcid":false,"given":"Michelle S.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna C.","family":"Dionne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1293-8496","authenticated-orcid":false,"given":"Steven M.","family":"Hollenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2195-0473","authenticated-orcid":false,"given":"Stephan M.","family":"Jakob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0594-0360","authenticated-orcid":false,"given":"Salmaan","family":"Kanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Leach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5449-2424","authenticated-orcid":false,"given":"Mark J.","family":"McPhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Monnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1042-6350","authenticated-orcid":false,"given":"Mervyn","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4250-7523","authenticated-orcid":false,"given":"Erika","family":"Wilkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Citerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"issue":"7","key":"8574_CR1","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1111\/j.1476-5381.2011.01588.x","volume":"165","author":"MN Bangash","year":"2012","unstructured":"Bangash MN, Kong ML, Pearse RM (2012) Use of inotropes and vasopressor agents in critically ill patients. Br J Pharmacol 165(7):2015\u20132033. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01588.x","journal-title":"Br J Pharmacol"},{"issue":"15","key":"8574_CR2","doi-asserted-by":"publisher","first-page":"8058","DOI":"10.3390\/ijms25158058","volume":"25","author":"AM Eraky","year":"2024","unstructured":"Eraky AM, Yerramalla Y, Khan A, Mokhtar Y, Alamrosy M, Farag A et al (2024) Beta-blockers as an immunologic and autonomic manipulator in critically ill patients: a review of the recent literature. Int J Mol Sci 25(15):8058. https:\/\/doi.org\/10.3390\/ijms25158058","journal-title":"Int J Mol Sci"},{"issue":"4","key":"8574_CR3","doi-asserted-by":"publisher","first-page":"R153","DOI":"10.1186\/cc11468","volume":"16","author":"H Schotola","year":"2012","unstructured":"Schotola H, Toischer K, Popov AF, Renner A, Schmitto JD, Gummert J et al (2012) Mild metabolic acidosis impairs the \u03b2-adrenergic response in isolated human failing myocardium. Crit Care 16(4):R153. https:\/\/doi.org\/10.1186\/cc11468","journal-title":"Crit Care"},{"issue":"3","key":"8574_CR4","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/00000658-196709000-00003","volume":"166","author":"MN Andersen","year":"1967","unstructured":"Andersen MN, Border JR, Mouritzen CV (1967) Acidosis, Catecholamines And Cardiovascular Dynamics: When Does Acidosis Require Correction? Ann Surg 166(3):344\u2013356. https:\/\/doi.org\/10.1097\/00000658-196709000-00003","journal-title":"Ann Surg"},{"issue":"1","key":"8574_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13613-021-00869-7","volume":"11","author":"M Carrara","year":"2021","unstructured":"Carrara M, Ferrario M, Bollen Pinto B, Herpain A (2021) The autonomic nervous system in septic shock and its role as a future therapeutic target: a narrative review. Ann Intensive Care 11(1):80. https:\/\/doi.org\/10.1186\/s13613-021-00869-7","journal-title":"Ann Intensive Care"},{"issue":"2","key":"8574_CR6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/01.ccm.0000048621.36569.69","volume":"31","author":"M Bucher","year":"2003","unstructured":"Bucher M, Kees F, Taeger K, Kurtz A (2003) Cytokines down-regulate alpha1-adrenergic receptor expression during endotoxemia. Crit Care Med 31(2):566\u2013571. https:\/\/doi.org\/10.1097\/01.ccm.0000048621.36569.69","journal-title":"Crit Care Med"},{"issue":"12","key":"8574_CR7","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s001340050768","volume":"24","author":"G Bernardin","year":"1998","unstructured":"Bernardin G, Strosberg AD, Bernard A, Mattei M, Marullo S (1998) Beta-adrenergic receptor-dependent and -independent stimulation of adenylate cyclase is impaired during severe sepsis in humans. Intensive Care Med 24(12):1315\u20131322. https:\/\/doi.org\/10.1007\/s001340050768","journal-title":"Intensive Care Med"},{"issue":"1","key":"8574_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41581-025-01004-6","volume":"22","author":"M Kox","year":"2026","unstructured":"Kox M, Bauer M, Bos LDJ, Bouma H, Calandra T, Calfee CS et al (2026) The immunology of sepsis: translating new insights into clinical practice. Nat Rev Nephrol 22(1):30\u201349. https:\/\/doi.org\/10.1038\/s41581-025-01004-6","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"8574_CR9","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00134-016-4249-z","volume":"42","author":"DT Andreis","year":"2016","unstructured":"Andreis DT, Singer M (2016) Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum. Intensive Care Med 42(9):1387\u20131397. https:\/\/doi.org\/10.1007\/s00134-016-4249-z","journal-title":"Intensive Care Med"},{"issue":"5","key":"8574_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/0885066609340519","volume":"24","author":"MW D\u00fcnser","year":"2009","unstructured":"D\u00fcnser MW, Hasibeder WR (2009) Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med 24(5):293\u2013316. https:\/\/doi.org\/10.1177\/0885066609340519","journal-title":"J Intensive Care Med"},{"issue":"34","key":"8574_CR11","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1093\/eurheartj\/ehaf340","volume":"46","author":"N Aissaoui","year":"2025","unstructured":"Aissaoui N, Boissier F, Chew M, Singer M, Vignon P (2025) Sepsis-induced cardiomyopathy. Eur Heart J 46(34):3339\u20133353. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf340","journal-title":"Eur Heart J"},{"key":"8574_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jcrc.2020.02.014","volume":"57","author":"R Domizi","year":"2020","unstructured":"Domizi R, Calcinaro S, Harris S, Beilstein C, Boerma C, Chiche JD et al (2020) Relationship between norepinephrine dose, tachycardia and outcome in septic shock: a multicentre evaluation. J Crit Care 57:185\u2013190. https:\/\/doi.org\/10.1016\/j.jcrc.2020.02.014","journal-title":"J Crit Care"},{"issue":"1","key":"8574_CR13","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1186\/s12879-024-10004-z","volume":"24","author":"YL Ning","year":"2024","unstructured":"Ning YL, Li WJ, Lu X, Zhang Y, Zhang JW, Zhou JH (2024) Association between heart rate and mortality in patients with septic shock: an analysis revealed by time series data. BMC Infect Dis 24(1):1088. https:\/\/doi.org\/10.1186\/s12879-024-10004-z","journal-title":"BMC Infect Dis"},{"issue":"2","key":"8574_CR14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s11739-025-03960-0","volume":"21","author":"Y Shen","year":"2025","unstructured":"Shen Y, Wang J, Cao Q, Wu Y, Wang Q, Wang N et al (2025) Maximum heart rate and mortality in sepsis patients: a retrospective cohort study. Intern Emerg Med 21(2):621\u2013630. https:\/\/doi.org\/10.1007\/s11739-025-03960-0","journal-title":"Intern Emerg Med"},{"issue":"1","key":"8574_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.chest.2024.08.020","volume":"167","author":"R Sato","year":"2025","unstructured":"Sato R, Messina S, Hasegawa D, Santonocito C, Scimonello G, Sanfilippo G et al (2025) Mortality in patients with sepsis treated with esmolol or landiolol: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. Chest 167(1):121\u2013138. https:\/\/doi.org\/10.1016\/j.chest.2024.08.020","journal-title":"Chest"},{"issue":"5","key":"8574_CR16","doi-asserted-by":"publisher","first-page":"e1125","DOI":"10.1097\/ccm.0000000000006604","volume":"53","author":"C McChesney","year":"2025","unstructured":"McChesney C, Orozco N, Fiorini K, Wong MYS, Slessarev M, Prager R et al (2025) Impact of short-acting beta-blockers on the outcomes of patients with septic shock: a systematic review and meta-analysis. Crit Care Med 53(5):e1125\u2013e1139. https:\/\/doi.org\/10.1097\/ccm.0000000000006604","journal-title":"Crit Care Med"},{"issue":"1","key":"8574_CR17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s13054-024-05174-w","volume":"28","author":"MG Alexandru","year":"2024","unstructured":"Alexandru MG, Niewald P, Kr\u00fcger S, Borgstedt R, Whitehouse T, Singer M et al (2024) Mortality in septic patients treated with short-acting betablockers: a comprehensive meta-analysis of randomized controlled trials. Crit Care 28(1):392. https:\/\/doi.org\/10.1186\/s13054-024-05174-w","journal-title":"Crit Care"},{"issue":"10","key":"8574_CR18","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1007\/s00134-024-07587-1","volume":"50","author":"S Rehberg","year":"2024","unstructured":"Rehberg S, Frank S, \u010cern\u00fd V, Cihl\u00e1\u0159 R, Borgstedt R, Biancofiore G et al (2024) Landiolol for heart rate control in patients with septic shock and persistent tachycardia A multicenter randomized clinical trial (Landi-SEP). Intensive Care Med 50(10):1622\u20131634. https:\/\/doi.org\/10.1007\/s00134-024-07587-1","journal-title":"Intensive Care Med"},{"issue":"6","key":"8574_CR19","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1097\/shk.0000000000002576","volume":"63","author":"S Lu","year":"2025","unstructured":"Lu S, Kattan E, Pan C, Shen J, Zhang T, Wang P et al (2025) Very early use of esmolol in hyperkinetic septic shock patients with persistent tachycardia: a randomized controlled pilot study. Shock 63(6):870\u2013877. https:\/\/doi.org\/10.1097\/shk.0000000000002576","journal-title":"Shock"},{"issue":"17","key":"8574_CR20","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1001\/jama.2023.20134","volume":"330","author":"T Whitehouse","year":"2023","unstructured":"Whitehouse T, Hossain A, Perkins GD, Gordon AC, Bion J, Young D et al (2023) Landiolol and organ failure in patients with septic shock: the STRESS-L randomized clinical trial. JAMA 330(17):1641\u20131652. https:\/\/doi.org\/10.1001\/jama.2023.20134","journal-title":"JAMA"},{"issue":"16","key":"8574_CR21","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jama.2013.278477","volume":"310","author":"A Morelli","year":"2013","unstructured":"Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S et al (2013) Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 310(16):1683\u20131691. https:\/\/doi.org\/10.1001\/jama.2013.278477","journal-title":"JAMA"},{"issue":"6","key":"8574_CR22","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.bja.2020.05.058","volume":"125","author":"A Morelli","year":"2020","unstructured":"Morelli A, Romano SM, Sanfilippo F, Santonocito C, Frati G, Chiostri M et al (2020) Systolic-dicrotic notch pressure difference can identify tachycardic patients with septic shock at risk of cardiovascular decompensation following pharmacological heart rate reduction. Br J Anaesth 125(6):1018\u20131024. https:\/\/doi.org\/10.1016\/j.bja.2020.05.058","journal-title":"Br J Anaesth"},{"issue":"1","key":"8574_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13054-020-03445-w","volume":"25","author":"B Levy","year":"2021","unstructured":"Levy B, Fritz C, Piona C, Duarte K, Morelli A, Guerci P et al (2021) Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study. Crit Care 25(1):21. https:\/\/doi.org\/10.1186\/s13054-020-03445-w","journal-title":"Crit Care"},{"issue":"1","key":"8574_CR24","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s13054-022-04255-y","volume":"26","author":"D De Backer","year":"2022","unstructured":"De Backer D, Cecconi M, Chew MS, Hajjar L, Monnet X, Ospina-Tasc\u00f3n GA et al (2022) A plea for personalization of the hemodynamic management of septic shock. Crit Care 26(1):372. https:\/\/doi.org\/10.1186\/s13054-022-04255-y","journal-title":"Crit Care"},{"issue":"39","key":"8574_CR25","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1093\/eurheartj\/ehac270","volume":"43","author":"S Halvorsen","year":"2022","unstructured":"Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E et al (2022) 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC). Eur Heart J 43(39):3826\u20133924. https:\/\/doi.org\/10.1093\/eurheartj\/ehac270","journal-title":"Eur Heart J"},{"issue":"38","key":"8574_CR26","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A et al (2023) 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 44(38):3720\u20133826. https:\/\/doi.org\/10.1093\/eurheartj\/ehad191","journal-title":"Eur Heart J"},{"issue":"5","key":"8574_CR27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1177\/2048872619830609","volume":"9","author":"NP Hoedemaker","year":"2020","unstructured":"Hoedemaker NP, Roolvink V, de Winter RJ, van Royen N, Fuster V, Garcia-Ruiz JM et al (2020) Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A patient-pooled meta-analysis of randomized clinical trials. Eur Heart J Acute Cardiovasc Care 9(5):469\u2013477. https:\/\/doi.org\/10.1177\/2048872619830609","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"8574_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.828614","volume":"9","author":"M Wang","year":"2022","unstructured":"Wang M, Liu J, Liu J, Hao Y, Yang N, Liu T et al (2022) Association between early oral \u03b2-blocker therapy and in-hospital outcomes in patients with ST-elevation myocardial infarction with mild-moderate heart failure: findings from the CCC-ACS project. Front Cardiovasc Med 9:828614. https:\/\/doi.org\/10.3389\/fcvm.2022.828614","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"8574_CR29","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.amjcard.2015.11.059","volume":"117","author":"R Bugiardini","year":"2016","unstructured":"Bugiardini R, Cenko E, Ricci B, Vasiljevic Z, Dorobantu M, Kedev S et al (2016) Comparison of early versus delayed oral \u03b2 blockers in acute coronary syndromes and effect on outcomes. Am J Cardiol 117(5):760\u2013767. https:\/\/doi.org\/10.1016\/j.amjcard.2015.11.059","journal-title":"Am J Cardiol"},{"issue":"suppl_21","key":"8574_CR30","first-page":"A14535-A","volume":"126","author":"S van Diepen","year":"2012","unstructured":"van Diepen S, Stebbins A, Reynolds HR, Dzavik V, Ruzyllo W, Hochman JS et al (2012) Abstract 14535: Early \u03b2-blocker and renin angiotensin aldosterone blocker therapy in patients with acute myocardial infarction and ongoing cardiogenic shock is associated with increased 30 day mortality: insights from the triumph trial. Circulation 126(suppl_21):A14535-A","journal-title":"Circulation"},{"issue":"5","key":"8574_CR31","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.3390\/biomedicines11051494","volume":"11","author":"N Wilmes","year":"2023","unstructured":"Wilmes N, van Luik EM, Vaes EWP, Vesseur MAM, Laven S, Mohseni-Alsalhi Z et al (2023) Exploring Sex Differences of Beta-Blockers in the Treatment of Hypertension: A Systematic Review and Meta-Analysis. Biomedicines. 11(5):1494. https:\/\/doi.org\/10.3390\/biomedicines11051494","journal-title":"Biomedicines."},{"issue":"10","key":"8574_CR32","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00134-023-07194-6","volume":"49","author":"H Merdji","year":"2023","unstructured":"Merdji H, Long MT, Ostermann M, Herridge M, Myatra SN, De Rosa S et al (2023) Sex and gender differences in intensive care medicine. Intensive Care Med 49(10):1155\u20131167. https:\/\/doi.org\/10.1007\/s00134-023-07194-6","journal-title":"Intensive Care Med"},{"issue":"13","key":"8574_CR33","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1161\/cir.0000000000000614","volume":"138","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB et al (2018) 2017 AHA\/ACC\/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation 138(13):e272\u2013e391. https:\/\/doi.org\/10.1161\/cir.0000000000000614","journal-title":"Circulation"},{"issue":"36","key":"8574_CR34","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns H et al (2024) 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 45(36):3314\u20133414. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176","journal-title":"Eur Heart J"},{"issue":"5","key":"8574_CR35","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1002\/ehf2.12879","volume":"7","author":"T Imamura","year":"2020","unstructured":"Imamura T, Kinugawa K (2020) Novel rate control strategy with landiolol in patients with cardiac dysfunction and atrial fibrillation. ESC Heart Fail 7(5):2208\u20132213. https:\/\/doi.org\/10.1002\/ehf2.12879","journal-title":"ESC Heart Fail"},{"key":"8574_CR36","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.resuscitation.2019.11.019","volume":"146","author":"M Gottlieb","year":"2020","unstructured":"Gottlieb M, Dyer S, Peksa GD (2020) Beta-blockade for the treatment of cardiac arrest due to ventricular fibrillation or pulseless ventricular tachycardia: A systematic review and meta-analysis. Resuscitation 146:118\u2013125. https:\/\/doi.org\/10.1016\/j.resuscitation.2019.11.019","journal-title":"Resuscitation"},{"issue":"5","key":"8574_CR37","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s00134-025-07895-0","volume":"51","author":"S Sibley","year":"2025","unstructured":"Sibley S, Bedford J, Wetterslev M, Johnston B, Garside T, Kanji S et al (2025) Atrial fibrillation in critical illness: state of the art. Intensive Care Med 51(5):904\u2013916. https:\/\/doi.org\/10.1007\/s00134-025-07895-0","journal-title":"Intensive Care Med"},{"key":"8574_CR38","doi-asserted-by":"publisher","first-page":"811","DOI":"10.2147\/clep.s485411","volume":"16","author":"HD Zhang","year":"2024","unstructured":"Zhang HD, Ding L, Mi LJ, Zhang AK, Liu YD, Li XN et al (2024) Impact of new-onset atrial fibrillation on mortality in critically Ill patients. Clin Epidemiol 16:811\u2013822. https:\/\/doi.org\/10.2147\/clep.s485411","journal-title":"Clin Epidemiol"},{"key":"8574_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2022.154161","volume":"72","author":"T Garside","year":"2022","unstructured":"Garside T, Bedford JP, Vollam S, Gerry S, Rajappan K, Watkinson PJ (2022) Increased long-term mortality following new-onset atrial fibrillation in the intensive care unit: a systematic review and meta-analysis. J Crit Care 72:154161. https:\/\/doi.org\/10.1016\/j.jcrc.2022.154161","journal-title":"J Crit Care"},{"issue":"Suppl 22","key":"8574_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12919-024-00309-x","volume":"18","author":"S Sibley","year":"2024","unstructured":"Sibley S, Atzema C, Balik M, Bedford J, Conen D, Garside T et al (2024) Research priorities for the study of atrial fibrillation during acute and critical illness: recommendations from the Symposium on Atrial Fibrillation in Acute and Critical Care. BMC Proc 18(Suppl 22):23. https:\/\/doi.org\/10.1186\/s12919-024-00309-x","journal-title":"BMC Proc"},{"issue":"8","key":"8574_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2023.100622","volume":"2","author":"M Zhu","year":"2023","unstructured":"Zhu M, Reyes KRL, Bilgili G, Siegel RJ, Lee Claggett B, Wong TC et al (2023) Medical therapies to improve left ventricular outflow obstruction and diastolic function in hypertrophic cardiomyopathy. JACC Adv 2(8):100622. https:\/\/doi.org\/10.1016\/j.jacadv.2023.100622","journal-title":"JACC Adv"},{"issue":"2","key":"8574_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2025-003460","volume":"12","author":"AJ Smith","year":"2025","unstructured":"Smith AJ, Cromie AMM, Bowles L, Anderson T, Panchal J, Walters B (2025) Beta blockers and hypertrophic obstructive cardiomyopathy: a systematic review and meta-analysis. Open Heart 12(2):e003460. https:\/\/doi.org\/10.1136\/openhrt-2025-003460","journal-title":"Open Heart"},{"issue":"2","key":"8574_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4250\/jcvi.2018.26.e9","volume":"26","author":"TS Kang","year":"2018","unstructured":"Kang TS, Park S (2018) Antihypertensive treatment in severe aortic stenosis. J Cardiovasc Imaging 26(2):45\u201353. https:\/\/doi.org\/10.4250\/jcvi.2018.26.e9","journal-title":"J Cardiovasc Imaging"},{"issue":"5","key":"8574_CR44","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.jacc.2009.02.077","volume":"54","author":"U Sampat","year":"2009","unstructured":"Sampat U, Varadarajan P, Turk R, Kamath A, Khandhar S, Pai RG (2009) Effect of beta-blocker therapy on survival in patients with severe aortic regurgitation results from a cohort of 756 patients. J Am Coll Cardiol 54(5):452\u2013457. https:\/\/doi.org\/10.1016\/j.jacc.2009.02.077","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"8574_CR45","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jacc.2009.04.035","volume":"54","author":"U Elkayam","year":"2009","unstructured":"Elkayam U (2009) Beta-blockers in the treatment of aortic regurgitation. JACC 54(5):458\u2013459. https:\/\/doi.org\/10.1016\/j.jacc.2009.04.035","journal-title":"JACC"},{"issue":"36","key":"8574_CR46","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"issue":"8","key":"8574_CR47","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jchf.2015.03.008","volume":"3","author":"KW Prins","year":"2015","unstructured":"Prins KW, Neill JM, Tyler JO, Eckman PM, Duval S (2015) Effects of beta-blocker withdrawal in acute decompensated heart failure: a systematic review and meta-analysis. JACC Heart Fail 3(8):647\u2013653. https:\/\/doi.org\/10.1016\/j.jchf.2015.03.008","journal-title":"JACC Heart Fail"},{"issue":"4","key":"8574_CR48","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1002\/ehf2.15322","volume":"12","author":"M Pagnesi","year":"2025","unstructured":"Pagnesi M, Riccardi M, Sacco A, Tavecchia G, Viola G, Frea S et al (2025) Pre-admission beta-blocker therapy and outcomes in cardiogenic shock: Insights from the Altshock-2 Registry. ESC Heart Fail 12(4):2565\u20132577. https:\/\/doi.org\/10.1002\/ehf2.15322","journal-title":"ESC Heart Fail"},{"issue":"1","key":"8574_CR49","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/ehf2.15322","volume":"25","author":"P Di Santo","year":"2021","unstructured":"Di Santo P, Mathew R, Jung RG, Simard T, Skanes S, Mao B et al (2021) Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial. Crit Care 25(1):289. https:\/\/doi.org\/10.1002\/ehf2.15322","journal-title":"Crit Care"},{"issue":"22","key":"8574_CR50","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/eurheartj\/ehy077","volume":"39","author":"JR Ghadri","year":"2018","unstructured":"Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ et al (2018) International expert consensus document on takotsubo syndrome (Part II): diagnostic workup, outcome, and management. Eur Heart J 39(22):2047\u20132062. https:\/\/doi.org\/10.1093\/eurheartj\/ehy077","journal-title":"Eur Heart J"},{"issue":"11","key":"8574_CR51","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00134-025-08137-z","volume":"51","author":"X Monnet","year":"2025","unstructured":"Monnet X, Messina A, Greco M, Bakker J, Aissaoui N, Cecconi M et al (2025) ESICM guidelines on circulatory shock and hemodynamic monitoring 2025. Intensive Care Med 51(11):1971\u20132012. https:\/\/doi.org\/10.1007\/s00134-025-08137-z","journal-title":"Intensive Care Med"},{"issue":"2","key":"8574_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.21037\/cdt-2025-1-676","volume":"16","author":"Y Yumita","year":"2026","unstructured":"Yumita Y, Nagatomo Y, Kawai A, Iwashita M, Mizutani K, Naito A et al (2026) Rethinking heart rate modulation in heart failure: physiological basis, clinical evidence, and individualized targets: a narrative review. Cardiovasc Diagn Ther 16(2):27. https:\/\/doi.org\/10.21037\/cdt-2025-1-676","journal-title":"Cardiovasc Diagn Ther"},{"issue":"9744","key":"8574_CR53","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/s0140-6736(10)61198-1","volume":"376","author":"K Swedberg","year":"2010","unstructured":"Swedberg K, Komajda M, B\u00f6hm M, Borer JS, Ford I, Dubost-Brama A et al (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376(9744):875\u2013885. https:\/\/doi.org\/10.1016\/s0140-6736(10)61198-1","journal-title":"Lancet"},{"key":"8574_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-077205","volume":"386","author":"JB Miller","year":"2024","unstructured":"Miller JB, Hrabec D, Krishnamoorthy V, Kinni H, Brook RD (2024) Evaluation and management of hypertensive emergency. BMJ 386:e077205. https:\/\/doi.org\/10.1136\/bmj-2023-077205","journal-title":"BMJ"},{"issue":"8","key":"8574_CR55","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1161\/hyp.0000000000000238","volume":"81","author":"AP Bress","year":"2024","unstructured":"Bress AP, Anderson TS, Flack JM, Ghazi L, Hall ME, Laffer CL et al (2024) The management of elevated blood pressure in the acute care setting: a scientific statement from the american heart association. Hypertension 81(8):e94\u2013e106. https:\/\/doi.org\/10.1161\/hyp.0000000000000238","journal-title":"Hypertension"},{"issue":"38","key":"8574_CR56","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C et al (2024) 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J 45(38):3912\u20134018. https:\/\/doi.org\/10.1093\/eurheartj\/ehae178","journal-title":"Eur Heart J"},{"issue":"24","key":"8574_CR57","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1016\/j.jacc.2022.08.004","volume":"80","author":"EM Isselbacher","year":"2022","unstructured":"Isselbacher EM, Preventza O, Hamilton Black Iii J, Augoustides JG, Beck AW, Bolen MA et al (2022) 2022 ACC\/AHA Guideline for the Diagnosis and Management of Aortic\u00a0Disease: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 80(24):e223\u2013e393. https:\/\/doi.org\/10.1016\/j.jacc.2022.08.004","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"8574_CR58","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/j.1875-9114.1983.tb03252.x","volume":"3","author":"EP MacCarthy","year":"1983","unstructured":"MacCarthy EP, Bloomfield SS (1983) Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects. Pharmacotherapy 3(4):193\u2013219. https:\/\/doi.org\/10.1002\/j.1875-9114.1983.tb03252.x","journal-title":"Pharmacotherapy"},{"key":"8574_CR59","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ejogrb.2024.11.002","volume":"303","author":"OR Gon\u00e7alves","year":"2024","unstructured":"Gon\u00e7alves OR, Bendaham L, Simoni GH, Kojima GSA, Faria HS, de Abreu VS et al (2024) Comparative efficacy and safety between intravenous labetalol and intravenous hydralazine for hypertensive disorders in pregnancy: A systematic review and meta-analysis of 19 randomized controlled trials. Eur J Obstet Gynecol Reprod Biol 303:337\u2013344. https:\/\/doi.org\/10.1016\/j.ejogrb.2024.11.002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"8574_CR60","unstructured":"Miller M, Maani CV. (2025) Labetalol. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC."},{"issue":"10","key":"8574_CR61","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/s41371-022-00776-9","volume":"37","author":"S Kulkarni","year":"2023","unstructured":"Kulkarni S, Glover M, Kapil V, Abrams SML, Partridge S, McCormack T et al (2023) Management of hypertensive crisis: British and Irish Hypertension Society Position document. J Hum Hypertens 37(10):863\u2013879. https:\/\/doi.org\/10.1038\/s41371-022-00776-9","journal-title":"J Hum Hypertens"},{"issue":"8","key":"8574_CR62","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.66694","volume":"16","author":"NN Khan","year":"2024","unstructured":"Khan NN, Zurayyir EJ, Alghamdi AM, Alghamdi SF, Alqahtani MA, Abdalla EM et al (2024) Management strategies for hypertensive crisis: a systematic review. Cureus 16(8):e66694. https:\/\/doi.org\/10.7759\/cureus.66694","journal-title":"Cureus"},{"issue":"1","key":"8574_CR63","doi-asserted-by":"publisher","DOI":"10.1136\/tsaco-2019-000307","volume":"4","author":"TJ Schroeppel","year":"2019","unstructured":"Schroeppel TJ, Sharpe JP, Shahan CP, Clement LP, Magnotti LJ, Lee M et al (2019) Beta-adrenergic blockade for attenuation of catecholamine surge after traumatic brain injury: a randomized pilot trial. Trauma Surg Acute Care Open 4(1):e000307. https:\/\/doi.org\/10.1136\/tsaco-2019-000307","journal-title":"Trauma Surg Acute Care Open"},{"issue":"1","key":"8574_CR64","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00068-024-02699-1","volume":"51","author":"J Hong","year":"2025","unstructured":"Hong J, Stoltzfus MT, Hallan DR, Jareczek FJ, Freedman Z, Bailey D et al (2025) Effects of early propranolol administration on mortality from severe, traumatic brain injury: a retrospective propensity score-matched registry study. Eur J Trauma Emerg Surg 51(1):44. https:\/\/doi.org\/10.1007\/s00068-024-02699-1","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"1","key":"8574_CR65","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11481-024-10121-1","volume":"19","author":"J Jae","year":"2024","unstructured":"Jae J, Li Y, Sun C, Allan A, Basmaji J, Chilton S et al (2024) Preclinical studies on mechanisms underlying the protective effects of propranolol in traumatic brain injury: a systematic review. J Neuroimmune Pharmacol 19(1):33. https:\/\/doi.org\/10.1007\/s11481-024-10121-1","journal-title":"J Neuroimmune Pharmacol"},{"issue":"5","key":"8574_CR66","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.bja.2019.07.017","volume":"123","author":"WM Armstead","year":"2019","unstructured":"Armstead WM, Vavilala MS (2019) Propranolol protects cerebral autoregulation and reduces hippocampal neuronal cell death through inhibition of interleukin-6 upregulation after traumatic brain injury in pigs. Br J Anaesth 123(5):610\u2013617. https:\/\/doi.org\/10.1016\/j.bja.2019.07.017","journal-title":"Br J Anaesth"},{"issue":"6","key":"8574_CR67","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/ta.0000000000003094","volume":"90","author":"H Ding","year":"2021","unstructured":"Ding H, Liao L, Zheng X, Wang Q, Liu Z, Xu G et al (2021) \u03b2-Blockers for traumatic brain injury: a systematic review and meta-analysis. J Trauma Acute Care Surg 90(6):1077\u20131085. https:\/\/doi.org\/10.1097\/ta.0000000000003094","journal-title":"J Trauma Acute Care Surg"},{"issue":"5","key":"8574_CR68","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1177\/00031348221101583","volume":"89","author":"I Zagales","year":"2023","unstructured":"Zagales I, Selvakumar S, Ngatuvai M, Fanfan D, Kornblith L, Santos RG et al (2023) Beta-blocker therapy in patients with severe traumatic brain injury: a systematic review and meta-analysis. Am Surg 89(5):2020\u20132029. https:\/\/doi.org\/10.1177\/00031348221101583","journal-title":"Am Surg"},{"issue":"9","key":"8574_CR69","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/s1474-4422(17)30259-4","volume":"16","author":"G Meyfroidt","year":"2017","unstructured":"Meyfroidt G, Baguley IJ, Menon DK (2017) Paroxysmal sympathetic hyperactivity: the storm after acute brain injury. Lancet Neurol 16(9):721\u2013729. https:\/\/doi.org\/10.1016\/s1474-4422(17)30259-4","journal-title":"Lancet Neurol"},{"issue":"2","key":"8574_CR70","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s12028-023-01755-9","volume":"40","author":"M Thomas","year":"2024","unstructured":"Thomas M, Hayes K, White P, Ramesh A, Culliford L, Ackland G et al (2024) Early intravenous beta-blockade with esmolol in adults with severe traumatic brain injury (EBB-TBI): protocol for a Phase 2a Intervention Design Study. Neurocrit Care 40(2):795\u2013806. https:\/\/doi.org\/10.1007\/s12028-023-01755-9","journal-title":"Neurocrit Care"},{"issue":"1","key":"8574_CR71","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1089\/neur.2024.0055","volume":"5","author":"T Baumer","year":"2024","unstructured":"Baumer T, Higginbotham G, Hayes K, Thomas M (2024) The effect of early beta-blockade with esmolol on therapy intensity level in adults with severe traumatic brain injury. Neurotrauma Rep 5(1):982\u2013987. https:\/\/doi.org\/10.1089\/neur.2024.0055","journal-title":"Neurotrauma Rep"},{"issue":"2","key":"8574_CR72","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s12028-023-01777-3","volume":"40","author":"G Coppalini","year":"2024","unstructured":"Coppalini G, Salvagno M, Peluso L, Bogossian EG, Quispe Cornejo A, Labb\u00e9 V et al (2024) Cardiac injury after traumatic brain injury: clinical consequences and management. Neurocrit Care 40(2):477\u2013485. https:\/\/doi.org\/10.1007\/s12028-023-01777-3","journal-title":"Neurocrit Care"},{"issue":"16","key":"8574_CR73","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/j.jacc.2018.07.072","volume":"72","author":"H de Medina Chazal","year":"2018","unstructured":"de Medina Chazal H, Del Buono MG, Keyser-Marcus L, Ma L, Moeller FG, Berrocal D et al (2018) Stress Cardiomyopathy Diagnosis and\u00a0Treatment: JACC State-of-the-Art Review. J Am Coll Cardiol 72(16):1955\u20131971. https:\/\/doi.org\/10.1016\/j.jacc.2018.07.072","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"8574_CR74","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1177\/08850666241236724","volume":"39","author":"M Kelly-Hedrick","year":"2024","unstructured":"Kelly-Hedrick M, Liu SY, Komisarow J, Hatfield J, Ohnuma T, Treggiari MM et al (2024) Early beta-blocker utilization in critically ill patients with moderate-severe traumatic brain injury: a retrospective cohort study. J Intensive Care Med 39(9):875\u2013882. https:\/\/doi.org\/10.1177\/08850666241236724","journal-title":"J Intensive Care Med"},{"issue":"1","key":"8574_CR75","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s44158-025-00316-0","volume":"6","author":"M Bouras","year":"2025","unstructured":"Bouras M, Beaulieu N, Torkomyan TH, O\u2019Connor S, Costerousse O, Lauzier F et al (2025) Beta-blockers in adults with acute traumatic brain injury: a systematic review and meta-analysis of randomized controlled trials. J Anesth Analg Crit Care 6(1):2. https:\/\/doi.org\/10.1186\/s44158-025-00316-0","journal-title":"J Anesth Analg Crit Care"},{"key":"8574_CR76","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2147\/clep.s268105","volume":"13","author":"HZ Balla","year":"2021","unstructured":"Balla HZ, Cao Y, Str\u00f6m JO (2021) Effect of beta-blockers on stroke outcome: a meta-analysis. Clin Epidemiol 13:225\u2013236. https:\/\/doi.org\/10.2147\/clep.s268105","journal-title":"Clin Epidemiol"},{"issue":"6","key":"8574_CR77","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.bja.2024.02.023","volume":"132","author":"N Glarner","year":"2024","unstructured":"Glarner N, Puelacher C, Gualandro DM, Pargger M, Hure G, Maiorano S et al (2024) Association of preoperative beta-blocker use and cardiac complications after major noncardiac surgery: a prospective cohort study. Br J Anaesth 132(6):1194\u20131203. https:\/\/doi.org\/10.1016\/j.bja.2024.02.023","journal-title":"Br J Anaesth"},{"issue":"9993","key":"8574_CR78","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/s0140-6736(15)60160-x","volume":"386","author":"JG Meara","year":"2015","unstructured":"Meara JG, Leather AJ, Hagander L, Alkire BC, Alonso N, Ameh EA et al (2015) Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet 386(9993):569\u2013624. https:\/\/doi.org\/10.1016\/s0140-6736(15)60160-x","journal-title":"Lancet"},{"issue":"2","key":"8574_CR79","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.atssr.2023.11.019","volume":"2","author":"D Vervoort","year":"2024","unstructured":"Vervoort D, Lee G, Ghandour H, Guetter CR, Adreak N, Till BM et al (2024) Global cardiac surgical volume and gaps: trends, targets, and way forward. Ann Thorac Surg Short Rep 2(2):320\u2013324. https:\/\/doi.org\/10.1016\/j.atssr.2023.11.019","journal-title":"Ann Thorac Surg Short Rep"},{"issue":"9627","key":"8574_CR80","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1016\/s0140-6736(08)60601-7","volume":"371","author":"PJ Devereaux","year":"2008","unstructured":"Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC et al (2008) Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371(9627):1839\u20131847. https:\/\/doi.org\/10.1016\/s0140-6736(08)60601-7","journal-title":"Lancet"},{"issue":"3","key":"8574_CR81","doi-asserted-by":"publisher","first-page":"CD004476","DOI":"10.1002\/14651858.cd004476.pub3","volume":"3","author":"H Blessberger","year":"2018","unstructured":"Blessberger H, Kammler J, Domanovits H, Schlager O, Wildner B, Azar D et al (2018) Perioperative beta-blockers for preventing surgery-related mortality and morbidity. Cochrane Database Syst Rev 3(3):CD004476. https:\/\/doi.org\/10.1002\/14651858.cd004476.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"8574_CR82","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1136\/heartjnl-2013-304262","volume":"100","author":"S Bouri","year":"2014","unstructured":"Bouri S, Shun-Shin MJ, Cole GD, Mayet J, Francis DP (2014) Meta-analysis of secure randomised controlled trials of beta-blockade to prevent perioperative death in non-cardiac surgery. Heart 100(6):456\u2013464. https:\/\/doi.org\/10.1136\/heartjnl-2013-304262","journal-title":"Heart"},{"issue":"4","key":"8574_CR83","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.athoracsur.2019.07.056","volume":"109","author":"G Filardo","year":"2020","unstructured":"Filardo G, da Graca B, Sass DM, Hamilton J, Pollock BD, Edgerton JR (2020) Preoperative beta-blockers as a coronary surgery quality metric: the lack of evidence of efficacy. Ann Thorac Surg 109(4):1150\u20131158. https:\/\/doi.org\/10.1016\/j.athoracsur.2019.07.056","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"8574_CR84","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/medsci12040064","volume":"12","author":"D Herrera Hernandez","year":"2024","unstructured":"Herrera Hernandez D, Abreu B, Xiao TS, Rojas A, Romero KL, Contreras V et al (2024) Beta-blocker use in patients undergoing non-cardiac surgery: a systematic review and meta-analysis. Med Sci (Basel) 12(4):64. https:\/\/doi.org\/10.3390\/medsci12040064","journal-title":"Med Sci (Basel)"},{"issue":"1","key":"8574_CR85","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/bja\/aew380","volume":"118","author":"S Hajibandeh","year":"2017","unstructured":"Hajibandeh S, Hajibandeh S, Antoniou SA, Torella F, Antoniou GA (2017) Effect of beta-blockers on perioperative outcomes in vascular and endovascular surgery: a systematic review and meta-analysis. Br J Anaesth 118(1):11\u201321. https:\/\/doi.org\/10.1093\/bja\/aew380","journal-title":"Br J Anaesth"},{"issue":"1","key":"8574_CR86","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezae355","volume":"67","author":"A Jeppsson","year":"2025","unstructured":"Jeppsson A, Rocca B, Hansson EC, Gudbjartsson T, James S, Kaski JC et al (2025) 2024 EACTS Guidelines on perioperative medication in adult cardiac surgery. Eur J Cardio-Thorac Surg 67(1):ezae355. https:\/\/doi.org\/10.1093\/ejcts\/ezae355","journal-title":"Eur J Cardio-Thorac Surg"},{"issue":"19","key":"8574_CR87","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1161\/CIR.0000000000001285","volume":"150","author":"A Thompson","year":"2024","unstructured":"Thompson A, Fleischmann KE, Smilowitz NR, de Las FL, Mukherjee D, Aggarwal NR et al (2024) 2024 AHA\/ACC\/ACS\/ASNC\/HRS\/SCA\/SCCT\/SCMR\/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 150(19):e351\u2013e442. https:\/\/doi.org\/10.1161\/CIR.0000000000001285","journal-title":"Circulation"},{"issue":"4","key":"8574_CR88","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1097\/aln.0b013e3181f1c061","volume":"113","author":"AW Wallace","year":"2010","unstructured":"Wallace AW, Au S, Cason BA (2010) Association of the pattern of use of perioperative beta-blockade and postoperative mortality. Anesthesiology 113(4):794\u2013805. https:\/\/doi.org\/10.1097\/aln.0b013e3181f1c061","journal-title":"Anesthesiology"},{"issue":"23","key":"8574_CR89","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1093\/eurheartj\/ehl272","volume":"27","author":"DC Burgess","year":"2006","unstructured":"Burgess DC, Kilborn MJ, Keech AC (2006) Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur Heart J 27(23):2846\u20132857. https:\/\/doi.org\/10.1093\/eurheartj\/ehl272","journal-title":"Eur Heart J"},{"issue":"4 Suppl","key":"8574_CR90","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.athoracsur.2007.01.053","volume":"83","author":"DM Shahian","year":"2007","unstructured":"Shahian DM, Edwards FH, Ferraris VA, Haan CK, Rich JB, Normand SL et al (2007) Quality measurement in adult cardiac surgery: part 1\u2013Conceptual framework and measure selection. Ann Thorac Surg 83(4 Suppl):S3-12. https:\/\/doi.org\/10.1016\/j.athoracsur.2007.01.053","journal-title":"Ann Thorac Surg"},{"issue":"10","key":"8574_CR91","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1097\/ccm.0b013e31825b9509","volume":"40","author":"A Macchia","year":"2012","unstructured":"Macchia A, Romero M, Comignani PD, Mariani J, D\u2019Ettorre A, Prini N et al (2012) Previous prescription of \u03b2-blockers is associated with reduced mortality among patients hospitalized in intensive care units for sepsis. Crit Care Med 40(10):2768\u20132772. https:\/\/doi.org\/10.1097\/ccm.0b013e31825b9509","journal-title":"Crit Care Med"},{"issue":"2","key":"8574_CR92","doi-asserted-by":"publisher","first-page":"R87","DOI":"10.1186\/cc10085","volume":"15","author":"S Christensen","year":"2011","unstructured":"Christensen S, Johansen MB, T\u00f8nnesen E, Larsson A, Pedersen L, Lemeshow S et al (2011) Preadmission beta-blocker use and 30-day mortality among patients in intensive care: a cohort study. Crit Care 15(2):R87. https:\/\/doi.org\/10.1186\/cc10085","journal-title":"Crit Care"},{"issue":"4","key":"8574_CR93","doi-asserted-by":"publisher","DOI":"10.1097\/hc9.0000000000000682","volume":"9","author":"RS Brown Jr","year":"2025","unstructured":"Brown RS Jr, Brown KA, Flamm S, Bejarano RE, Rahimi RS, Singal AK et al (2025) Screening and management of portal hypertension and varices in cirrhosis: Expert perspectives. Hepatol Commun 9(4):e0682. https:\/\/doi.org\/10.1097\/hc9.0000000000000682","journal-title":"Hepatol Commun"},{"issue":"10","key":"8574_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastha.2025.100761","volume":"4","author":"OS Rudra","year":"2025","unstructured":"Rudra OS, Jindal A, Sarin SK (2025) Use of Noninvasive Tests to Assess Clinically Significant Portal Hypertension and Response to Beta-Blockers. Gastro Hep Adv 4(10):100761. https:\/\/doi.org\/10.1016\/j.gastha.2025.100761","journal-title":"Gastro Hep Adv"},{"issue":"6","key":"8574_CR95","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/jgh.16999","volume":"40","author":"A Joshi","year":"2025","unstructured":"Joshi A, Raja HAA, Roy P, Latif F, Reji RG, Deb N et al (2025) Comparison of Carvedilol to Propranolol in Reduction of Hepatic Venous Pressure Gradient in Liver Cirrhosis: A Meta-Analysis. J Gastroenterol Hepatol 40(6):1409\u20131418. https:\/\/doi.org\/10.1111\/jgh.16999","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"8574_CR96","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1097\/hep.0000000000000647","volume":"79","author":"DE Kaplan","year":"2024","unstructured":"Kaplan DE, Ripoll C, Thiele M, Fortune BE, Simonetto DA, Garcia-Tsao G et al (2024) AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis. Hepatology 79(5):1180\u20131211. https:\/\/doi.org\/10.1097\/hep.0000000000000647","journal-title":"Hepatology"},{"issue":"1","key":"8574_CR97","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/hep.28906","volume":"65","author":"G Garcia-Tsao","year":"2017","unstructured":"Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J (2017) Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology 65(1):310\u2013335. https:\/\/doi.org\/10.1002\/hep.28906","journal-title":"Hepatology"},{"issue":"11","key":"8574_CR98","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/bjaed\/mkx023","volume":"17","author":"DE Kerr","year":"2017","unstructured":"Kerr DE, Wenham T, Newell-Price J (2017) Endocrine problems in the critically ill 2: endocrine emergencies. BJA Education 17(11):377\u2013382. https:\/\/doi.org\/10.1093\/bjaed\/mkx023","journal-title":"BJA Education"},{"issue":"3","key":"8574_CR99","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/2042018810382481","volume":"1","author":"R Carroll","year":"2010","unstructured":"Carroll R, Matfin G (2010) Endocrine and metabolic emergencies: thyroid storm. Ther Adv Endocrinol Metab 1(3):139\u2013145. https:\/\/doi.org\/10.1177\/2042018810382481","journal-title":"Ther Adv Endocrinol Metab"},{"key":"8574_CR100","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ajem.2023.03.035","volume":"69","author":"S Farooqi","year":"2023","unstructured":"Farooqi S, Raj S, Koyfman A, Long B (2023) High risk and low prevalence diseases: Thyroid storm. Am J Emerg Med 69:127\u2013135. https:\/\/doi.org\/10.1016\/j.ajem.2023.03.035","journal-title":"Am J Emerg Med"},{"issue":"13","key":"8574_CR101","doi-asserted-by":"publisher","first-page":"6080","DOI":"10.3390\/ijms26136080","volume":"26","author":"AJ Gombert","year":"2025","unstructured":"Gombert AJ, Nerantzinis AM, Li J, Wang W, Yeung IY, Costa A et al (2025) The Perioperative Biochemical and Clinical Considerations of Pheochromocytoma Management. Int J Mol Sci 26(13):6080. https:\/\/doi.org\/10.3390\/ijms26136080","journal-title":"Int J Mol Sci"},{"issue":"9","key":"8574_CR102","doi-asserted-by":"publisher","first-page":"e1869","DOI":"10.1097\/ccm.0000000000006815","volume":"53","author":"J Downar","year":"2025","unstructured":"Downar J, Lapenskie J, Kanji S, Watpool I, Haines J, Saeed U et al (2025) Propranolol As an Anxiolytic to Reduce the Use of Sedatives for Critically Ill Adults Receiving Mechanical Ventilation (PROACTIVE): An Open-Label Randomized Controlled Trial: Erratum. Crit Care Med 53(9):e1869\u2013e1870. https:\/\/doi.org\/10.1097\/ccm.0000000000006815","journal-title":"Crit Care Med"},{"issue":"4","key":"8574_CR103","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/aco.0000000000001651","volume":"39","author":"J Zivadinovic","year":"2026","unstructured":"Zivadinovic J, Nikolic A, Jankovic R (2026) Dexmedetomidine: an update. Curr Opin Anaesthesiol 39(4):444\u2013448. https:\/\/doi.org\/10.1097\/aco.0000000000001651","journal-title":"Curr Opin Anaesthesiol"},{"issue":"9","key":"8574_CR104","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/0753-3322(92)90047-b","volume":"46","author":"D Bailly","year":"1992","unstructured":"Bailly D, Servant D, Blandin N, Beuscart R, Parquet PJ (1992) Effects of beta-blocking drugs in alcohol withdrawal: a double-blind comparative study with propranolol and diazepam. Biomed Pharmacother 46(9):419\u2013424. https:\/\/doi.org\/10.1016\/0753-3322(92)90047-b","journal-title":"Biomed Pharmacother"},{"issue":"3S","key":"8574_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/adm.0000000000000668","volume":"14","author":"ASAM The","year":"2020","unstructured":"The ASAM (2020) Clinical Practice Guideline on Alcohol Withdrawal Management. J Addict Med 14(3S):1\u201372. https:\/\/doi.org\/10.1097\/adm.0000000000000668","journal-title":"J Addict Med"},{"issue":"5","key":"8574_CR106","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/add.15265","volume":"116","author":"P Vanderkam","year":"2021","unstructured":"Vanderkam P, Solinas M, Ingrand I, Doux N, Ebrahimighavam S, Jaafari N et al (2021) Effectiveness of drugs acting on adrenergic receptors in the treatment for tobacco or alcohol use disorders: systematic review and meta-analysis. Addiction 116(5):1011\u20131020. https:\/\/doi.org\/10.1111\/add.15265","journal-title":"Addiction"},{"issue":"1","key":"8574_CR107","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/ta.0000000000000264","volume":"77","author":"LE Bible","year":"2014","unstructured":"Bible LE, Pasupuleti LV, Alzate WD, Gore AV, Song KJ, Sifri ZC et al (2014) Early propranolol administration to severely injured patients can improve bone marrow dysfunction. J Trauma Acute Care Surg 77(1):54\u201360. https:\/\/doi.org\/10.1097\/ta.0000000000000264 (discussion 59-60)","journal-title":"J Trauma Acute Care Surg"},{"issue":"4","key":"8574_CR108","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1097\/ta.0b013e3181684cf0","volume":"64","author":"RS Friese","year":"2008","unstructured":"Friese RS, Barber R, McBride D, Bender J, Gentilello LM (2008) Could Beta blockade improve outcome after injury by modulating inflammatory profiles? J Trauma 64(4):1061\u20131068. https:\/\/doi.org\/10.1097\/ta.0b013e3181684cf0","journal-title":"J Trauma"},{"issue":"9","key":"8574_CR109","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ijsu.2012.08.004","volume":"10","author":"JM Havens","year":"2012","unstructured":"Havens JM, Carter C, Gu X, Rogers SO Jr (2012) Preinjury beta blocker usage does not affect the heart rate response to initial trauma resuscitation. Int J Surg 10(9):518\u2013521. https:\/\/doi.org\/10.1016\/j.ijsu.2012.08.004","journal-title":"Int J Surg"},{"issue":"5","key":"8574_CR110","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1097\/ta.0000000000002204","volume":"86","author":"RA Tessler","year":"2019","unstructured":"Tessler RA, Rangel MM, Rosser ML, Rivara FP, Bulger E, Vavilala MS et al (2019) Complications in low-risk older adult trauma patients: A case-control study. J Trauma Acute Care Surg 86(5):858\u2013863. https:\/\/doi.org\/10.1097\/ta.0000000000002204","journal-title":"J Trauma Acute Care Surg"},{"issue":"7","key":"8574_CR111","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/000313481608200721","volume":"82","author":"LE Hendrick","year":"2016","unstructured":"Hendrick LE, Schroeppel TJ, Sharpe JP, Alsbrook D, Magnotti LJ, Weinberg JA et al (2016) Impact of Beta-Blockers on Nonhead Injured Trauma Patients. Am Surg 82(7):575\u2013579. https:\/\/doi.org\/10.1177\/000313481608200721","journal-title":"Am Surg"},{"issue":"1","key":"8574_CR112","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13049-021-00947-6","volume":"29","author":"L Sadi","year":"2021","unstructured":"Sadi L, Sj\u00f6lin G, Ahl HR (2021) Beta-blockade is not associated with improved outcomes in isolated severe extracranial injury: an observational cohort study. Scand J Trauma Resusc Emerg Med 29(1):132. https:\/\/doi.org\/10.1186\/s13049-021-00947-6","journal-title":"Scand J Trauma Resusc Emerg Med"},{"issue":"1","key":"8574_CR113","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/ta.0000000000000887","volume":"80","author":"O Flores","year":"2016","unstructured":"Flores O, Stockton K, Roberts JA, Muller MJ, Paratz JD (2016) The efficacy and safety of adrenergic blockade after burn injury: A systematic review and meta-analysis. J Trauma Acute Care Surg 80(1):146\u2013155. https:\/\/doi.org\/10.1097\/ta.0000000000000887","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"8574_CR114","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1111\/iwj.13478","volume":"17","author":"J Ma","year":"2020","unstructured":"Ma J, Hu D, Feng Z, Tang J, Guo L, Du Y et al (2020) The effectiveness and safety of beta antagonist in burned patients: A systematic review and meta-analysis. Int Wound J 17(6):1881\u20131892. https:\/\/doi.org\/10.1111\/iwj.13478","journal-title":"Int Wound J"},{"issue":"8","key":"8574_CR115","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1177\/0885066620940188","volume":"36","author":"N Hassoun-Kheir","year":"2021","unstructured":"Hassoun-Kheir N, Henig O, Avni T, Leibovici L, Paul M (2021) The Effect of \u03b2-Blockers for Burn Patients on Clinical Outcomes: Systematic Review and Meta-Analysis. J Intensive Care Med 36(8):945\u2013953. https:\/\/doi.org\/10.1177\/0885066620940188","journal-title":"J Intensive Care Med"},{"issue":"11","key":"8574_CR116","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1136\/thoraxjnl-2012-201945","volume":"67","author":"MS Stefan","year":"2012","unstructured":"Stefan MS, Rothberg MB, Priya A, Pekow PS, Au DH, Lindenauer PK (2012) Association between \u03b2-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension. Thorax 67(11):977\u2013984. https:\/\/doi.org\/10.1136\/thoraxjnl-2012-201945","journal-title":"Thorax"},{"issue":"1","key":"8574_CR117","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12916-017-0781-0","volume":"15","author":"DR Morales","year":"2017","unstructured":"Morales DR, Lipworth BJ, Donnan PT, Jackson C, Guthrie B (2017) Respiratory effect of beta-blockers in people with asthma and cardiovascular disease: population-based nested case control study. BMC Med 15(1):18. https:\/\/doi.org\/10.1186\/s12916-017-0781-0","journal-title":"BMC Med"},{"issue":"1","key":"8574_CR118","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41598-020-79837-3","volume":"11","author":"K-Y Huang","year":"2021","unstructured":"Huang K-Y, Tseng P-T, Wu Y-C, Tu Y-K, Stubbs B, Su K-P et al (2021) Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials. Sci Rep 11(1):452. https:\/\/doi.org\/10.1038\/s41598-020-79837-3","journal-title":"Sci Rep"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08574-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-026-08574-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08574-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:02:46Z","timestamp":1790726566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-026-08574-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":118,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["8574"],"URL":"https:\/\/doi.org\/10.1007\/s00134-026-08574-4","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"8 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MO has received research funding from bioMerieux and Baxter. DDB has received honoraria from AOP Health, Abbott, Viatris, Pharmazz. MSC has received honoraria from AOP Health, GE Health, Philips Healthcare and Laboratoire Aguettant. SMJ receives honoraria from Curie Bio Operations, LLC, Boston, MA. MJM has received honoraria from Merz Pharmaceuticals. MS (or Institution) has received honoraria from Abbott, AOP Health, Aprarion, Bayer, Biotest, Biomerieux, Deltex Medical, deePull, Matisse, Radiometer, Roche Diagnostics, Sanofi and Volition.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"Maurizio Cecconi and Michelle Chew are Associate Editors of Intensive Care Medicine. They have not taken part in the review or selection process of this article.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declaration"}}]}}